SusanBalMD

PubMed

• Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta-analysis.
  Nadia M Anabtawi, Monica Sai Pasala, Alyssa A Grimshaw, Prakash Kharel, Thomas W Buford, Susan Bal, Kelly Godby, Ashmita Siwakoti, Smita Bhatia, Luciano J Costa, Grant...> ;Journal of Cachexia, Sarcopenia and Muscle. 2024 Apr 1
• Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations.
  Gayathri Ravi, Susan Bal, Laura Joiner, Smit Giri, Melissa Sentell, Tiffany Hill, Kelly N Godby, Luciano J Costa> ;British Journal of Haematology. 2024 Apr 1
• Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma.
  Susan Bal, Luciano J Costa> ;British Journal of Haematology. 2024 Feb 1
• 1 citations
  Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies.
  Susan Bal, Noel Estrada-Merly, Luciano J Costa, Muzaffar H Qazilbash, Shaji Kumar, Anita D'Souza> ;Blood Cancer Journal. 2023 Nov 15
• 4 citations
  Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.
  Costa, L., Chhabra, S., Medvedova, E., Dholaria, B., Schmidt, T., Godby, K., Silbermann, R., Dhakal, B., Bal, S., Giri, S., D'Souza, A., Hall, A., Hardwick, P., Omel, ...> ;The Lancet. Haematology. 2023 Nov 1
• 1 citations
  Teclistamab in patients with multiple myeloma and impaired renal function.
  Laura Joiner, Susan Bal, Kelly N Godby, Luciano J Costa> ;American Journal of Hematology. 2023 Nov 1
• 13 citations
  Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma.
  Meera Mohan, Rajshekhar Chakraborty, Susan Bal, Anoma Nellore, Muhamed Baljevic, Anita D'Souza, Peter G Pappas, Jesus G Berdeja, Natalie Callander, Luciano J Costa> ;British Journal of Haematology. 2023 Dec 1
• 4 citations
  Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma.
  Luciano J Costa, Smith Giri, Susan Bal, Gayathri Ravi, Kelly N Godby> ;British Journal of Haematology. 2023 Mar 1
• Editorial: Advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosis.
  Susan Bal, Samuel Rubinstein, Bhutani, D.> ;Frontiers in Oncology. 2023 Jan 1
• 13 citations
  Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER ...
  Saurabh Chhabra, Natalie Callander, Nicole L Watts, Luciano J Costa, Bicky Thapa, Jonathan L Kaufman, Jacob Laubach, Douglas W Sborov, Brandi Reeves, Cesar Rodriguez, ...> ;Transplantation and Cellular Therapy. 2023 Mar 1
• 3 citations
  Clinical implications of measurable residual disease assessment in multiple myeloma in the era of quadruplet therapy.
  Susan Bal, Timothy M Schmidt, Luciano J Costa, Natalie S Callander> ;Leukemia & Lymphoma. 2022 Dec 1
• 98 citations
  Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.
  Costa, L., Chhabra, S., Medvedova, E., Dholaria, B., Schmidt, T., Godby, K., Silbermann, R., Dhakal, B., Bal, S., Giri, S., D'Souza, A., Hall, A., Hardwick, P., Omel, ...> ;Journal of Clinical Oncology. 2022 Sep 1
• 1 citations
  Disparities in clinical trial participation among older adults with multiple myeloma in the United States.
  Priscila White, Abigail Cooley, Susan Bal, Kelly Godby, Gayathri Ravi, Deanna Clark, Clare Ubersax, Grant R Williams, Luciano J Costa, Smith Giri> ;Journal of Geriatric Oncology. 2022 Nov 1
• Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cel...
  Sean Patrick Bliven, Lauren Shea, Susan Bal, Gaurav Goyal, Amitkumar Mehta, Mayur Narkhede> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Nov 1
• 2 citations
  Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma.
  Smith Giri, Sumit Dahal, Susan Bal, Kelly N Godby, Joshua Richman, Adam J Olszewski, Grant R Williams, Cynthia Brown, Thomas W Buford, Luciano J Costa, Bhatia, S.> ;Journal of Geriatric Oncology. 2022 May 1
• 2 citations
  Revisiting the impact of immunoglobulin isotypes in multiple myeloma.
  Susan Bal, Smith Giri, Kelly N Godby, Luciano J Costa> ;Annals of Hematology. 2022 Apr 1
• 3 citations
  Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow...
  Hemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, Hassan B Alkhateeb, Susan Bal, Mohamed A Kharfan-Dabaja, Bhagirathbhai Dholaria, Francine Foss, Lohith Gowda, Deepa...> ;Transplantation and Cellular Therapy. 2022 Apr 1
• 7 citations
  Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma.
  Smith Giri, Susan Bal, Kelly N Godby, Gayathri Ravi, Deanna Clark, Clare Ubersax, Abigail Cooley, Priscila White, Sunil Rangarajan, Grant R Williams, Luciano J Costa> ;American Journal of Hematology. 2022 Apr 1
• 9 citations
  Multiple myeloma with t(11;14): unique biology and evolving landscape.
  Susan Bal, Shaji K Kumar, Rafael Fonseca, Francesca Gay, Vania Tm Hungria, Ahmet Dogan, Luciano J Costa> ;American Journal of Cancer Research. 2022 Jan 1
• 8 citations
  AL amyloidosis: untangling new therapies.
  Susan Bal, Heather Landau> ;Hematology. American Society of Hematology. Education Program. 2021 Dec 10
• 18 citations
  Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies.
  Susan Bal, Ehsan Malek, Ankit Kansagra, Saad Z. Usmani, Ravi Vij, Kelly N. Godby, Yubin Kang, Elvira Umyarova, Smith Giri, Saurabh Chhabra, Michaela Liedtke, Natalie S...> ;Leukemia. 2021 Nov 20
• 2 citations
  A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients.
  Carlyn Tan, Noel Estrada-Merly, Heather Landau, Lazaros J. Lekakis, Rahul Banerjee, Hira S. Mian, Saad Z. Usmani, Amr Hanbali, Hillard M. Lazarus, Robert A. Kyle, Bhag...> ;Bone Marrow Transplantation. 2021 Nov 20
• 2 citations
  Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, m...
  Omer Jamy, Raquel Innis-Shelton, Susan Bal, Ravi Kumar Paluri, Donna Salzman, Antonio Di Stasi, Luciano J. Costa, Ruby F. Meredith, Lawrence S. Lamb, Kentaro Minagawa,...> ;American Journal of Hematology. 2021 Jul 31
• 3 citations
  Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myeloma.
  Susan Bal, Smith Giri, Kelly N. Godby, Luciano J. Costa> ;British Journal of Haematology. 2021 Jun 24
• 2 citations
  Maintaining the minimal: dynamics of measurable residual disease with continuous lenalidomide therapy.
  Susan Bal, Luciano J. Costa> ;The Lancet. Haematology. 2021 Jun 1
• Join now to see all

Journal Articles

• Caution with Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma—Reply  
  Susan Bal, MD, JAMA Oncology
• Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-Risk Cytogenetic Factors  
  Susan Bal, Benjamin Djulbegovic, Saad Z Usmani, JAMA Oncology